Key result
99mTc-sestamibi underestimates hyperemic flow disparity more than 201Tl during adenosine vasodilation.
Why the study?
Myocardial uptake of 201Tl and 99mTc-sestamibi plateaus at high coronary flow rates, but few direct comparisons had examined how differences in these plateaus affect the detection of coronary stenoses of varying severities.
Does 99mTc-sestamibi uptake differ from 201Tl uptake in reflecting coronary flow disparities during adenosine-induced vasodilation in a canine model of coronary stenosis?
Does 99mTc-sestamibi uptake differ from 201Tl uptake in reflecting coronary flow disparities during adenosine-induced vasodilation in a canine model of coronary stenosis?
Answers are grounded in this paper and cite their sources.
In a canine model, both 201Tl and 99mTc-sestamibi significantly underestimated the magnitude of flow disparity between stenotic and normal perfusion beds during adenosine-induced hyperemia, with sestamibi showing greater underestimation.
BACKGROUND: Myocardial uptake of either 201Tl or 99mTc-sestamibi (sestamibi) is known to plateau at high coronary flow rates. However, few direct comparisons have been made between these tracers to determine what effect differences in the uptake plateau for the two tracers may have on the detection of coronary stenoses of various severities. METHODS AND RESULTS: Twenty-two dogs were instrumented with flow transducers on the left anterior descending (LAD) and circumflex (LCx) arteries. In 6 nonstenotic dogs, adenosine was infused directly into the LAD, whereas 16 dogs with either critical (n = 7) or mild (n = 9) LAD stenoses received an intravenous infusion. At peak flow, 201Tl (0.5 mCi), sestamibi (5 to 8 mCi), and radiolabeled microspheres were injected simultaneously. Five minutes later, dogs were killed, and ex vivo imaging of heart slices and gamma-well counting of multiple myocardial samples was performed. Neither 201Tl nor sestamibi uptake increased in direct proportion to flow. In the 6 nonstenotic dogs, a fivefold increase in LAD flow increased 201Tl and sestamibi uptake by only 202 +/- 6% and 138 +/- 4%, respectively (P < .0001). In the dogs with critical stenosis, the ratios of stenotic to normal activity by well counting for 201Tl (0.37 +/- 0.05) and sestamibi (0.53 +/- 0.06) underestimated the microsphere-determined flow disparity (0.17 +/- 0.03) (P < .005), but the degree of underestimation was greater for sestamibi (P = .001). Similarly, in the dogs with mild stenosis, the stenotic-to-normal ratio for 201Tl (0.62 +/- 0.04) approximated the flow ratio (0.43 +/- 0.04) better than sestamibi (0.79 +/- 0.03) (P < .0001). Sestamibi defects, however, were visually identifiable on the images of the myocardial slices. By image quantification, sestamibi defect magnitude (LAD-to-LCx count ratio) in the critical stenosis group (0.62 +/- 0.05) was significantly less than in the mild stenosis group (0.80 +/- 0.02) (P < .01). CONCLUSIONS: Thus, with adenosine-induced hyperemic flow, both 201Tl and sestamibi significantly underestimated the magnitude of the flow disparity between stenotic and normal perfusion beds. The degree of underestimation was greater for sestamibi. The clinical implication of these experimental findings for vasodilator perfusion imaging remains to be determined, since factors such as greater redistribution and scatter with 201Tl could offset its advantages.
No takes yet. Share an insight, caveat, or question.
Glover et al. (1995) studied Coronary stenosis (n=22). 99mTc-sestamibi vs. 201Tl was evaluated on Ratio of stenotic to normal activity compared to microsphere-determined flow disparity (p=0.001). During adenosine-induced hyperemia in dogs, both 201Tl and 99mTc-sestamibi underestimated flow disparity, with sestamibi showing greater underestimation.
Synapse has enriched 10 related papers. Consider them for comparative context: